President Donald Trump met with Finland’s President in the Oval Office. The Trump administration reached a drug pricing agreement with AstraZeneca to lower prices in the U.S. This follows a similar deal with Pfizer. AstraZeneca will offer drugs to Medicaid patients at the lowest price from other developed countries on TrumpRx.gov. AstraZeneca will invest $50 billion in the U.S. by 2030. Trump aims to strike more pricing deals with major drugmakers.

Read more at CNBC: Trump reaches drug pricing deal with AstraZeneca